STOCKS | Heartway Medical Expects First-Half Revenue of at Least RMB 280 Million

Heartway Medical said it expects revenue for the six months ended June 30, 2026, to be at least RMB 280 million, up at least 50.9% from RMB 185 million a year earlier. According to Jin10, the company also said net profit is expected to be at least RMB 60 million, while adjusted net profit is expected to be at least RMB 70 million. The company said the growth was mainly due to revenue growth, driven by wider recognition of its products among customers, expanded business coverage, and rapid revenue growth across its three core businesses. It said the increase in adjusted net profit was mainly due to a higher revenue contribution from high-margin products and improved operating efficiency.